Language of instruction
The course covers theoretical and practical aspects of molecular cancer biomarkers and how these can be studied in patient samples and material from various types of experimental models. The course will focus on methods to study tissue samples, blood samples, urin samples, and other biologic materials, like immunohistochemistry, in situ hybridization, PCR-techniques and sequencing, Western blot and ELISA, microarray methods, proteomics, circulating tumor cells and DNA, flow cytometry, bioinformatics and biobanks. Changes in nucleic acids and proteins in different settings will be covered.
Upon completing this course the candidate should have:
- Evaluation of the expediency and application of basic methods in biomarker research on tissue samples, such as immunohistochemistry protocols and in situ hybridization.
- Good understanding of:
- PCR techniques and sequencing strategies.
- Western blot and ELISA techniques.
- Microarray analysis.
- Circulating and disseminated tumor cells.
- Flow cytometry.
- Cell free DNA analysis.
- Bioinformatics strategies.
- Can formulate problems, plan and carry out research on cancer biomarkers.
- Be able to assess the expediency and application of different methods in biomarker cancer research.
- Be able to communicate relevant literature and methods concerning molecular cancer biomarkers
- Be able to evaluate how knowledge about molecular cancer biomarkers can help in understanding tumor biological mechanisms and as a guide to improved diagnosis, targeted treatment and follow up of cancer patients.
27 - 29 August 2018
5 study points (125-150 hours student work time).
Course registration and deadlines
Register via StudentWeb.
Deadline: 1st of February/1st of September
Master's degree or equivalent education level is required, with the exception of students on the Medical Student Research Programme.
Recommended previous knowledge
Medical or health related educational background or PhD project related to medical / health related research.
Part of training component
Recommended as part of the training component for all candidates affiliated with the Research School for Cancer Studies (RSCS).
Form of assessment
To pass the course, the candidate must:
- Participate during at least 90% of the course.
- Participate actively in the group.
- 10-15 min long oral presentation to the other participants about a method related to own project.
- Pass a one hour written exam. The exam will be evaluated by the course-coordinator.
pass / fail.
Who may participate
The course is primarily intended for PhD candidates who are affiliated with the Centre for Cancer Biomarkers (CCBIO), but is also open to other students, PhD candidates and students at the Medical Student Research Program.
3 full days with lectures and seminars.
Group discussions with individual presentations.
Reading curriculum (see mandatory reading).
Solveig Lund Witsø
Lars A. Akslen and James Lorens.
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis by Debmalya Barh, Angelo Carpi, Mukesh Verma and Mehmet Gunduz (2014) 973 pages.
Cancer Biomarkers by Alexandros G Georgakilas (2012) 382 pages.
(Total 1355 pages).
Type of assessment: Take-home examination
- Withdrawal deadline
- Examination system
- Digital exam